Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics
Sarp Uzun, Carl Zinner, Amke C. Beenen, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 666-676
Open Access | Times Cited: 13

Showing 13 citing articles:

Global burden of vaccine‐associated hepatobiliary and gastrointestinal adverse drug reactions, 1967–2023: A comprehensive analysis of the international pharmacovigilance database
Sooji Lee, Kyeongmin Lee, Jaeyu Park, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 7
Closed Access | Times Cited: 10
Glycyrrhizic acid restores the downregulated hepatic ACE2 signaling in the attenuation of mouse steatohepatitis
Longyue Zhou, Shankang Chen, Yuanyi Wei, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176365-176365
Closed Access | Times Cited: 5
Update in Clinical Science: Autoimmune Hepatitis
Michael A. Heneghan, Ansgar W. Lohse
Journal of Hepatology (2025)
Open Access
Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations
Chaojie Yu, Wenrui Wang, Qian Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Drug Induced Liver Injury: Highlights and Controversies in the 2023 Literature
Harjit Singh, Bryce Kunkle, Angela Troia, et al.
Drug Safety (2025)
Closed Access
Single-cell omics in tracing cellular heterogeneity of drug-induced liver injury: Technological landscape and prospective application
Xia Mao, Mingzhu Xu, Xiangying Yan, et al.
hLife (2024) Vol. 2, Iss. 7, pp. 325-341
Open Access | Times Cited: 4
Being associated with multiple diseases, CD79a, as a B-cell marker plays an important role in disease treatment and prognosis
S Q Guan
Deleted Journal (2024), pp. 1-13
Closed Access
Genetic and Genomic Approaches to the Study of Drug‐Induced Liver Injury
Ann K. Daly
Liver International (2024) Vol. 45, Iss. 1
Open Access
Emerging Roles of Spatial Transcriptomics in Liver Research
Naoto Fujiwara, Genki Kimura, Hayato Nakagawa
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 115-132
Closed Access
Diagnostic features of autoimmune hepatitis in SARS‑CoV‑2‑vaccinated vs. unvaccinated individuals
Akifumi Kuwano, Shigehiro Nagasawa, Yuta Koga, et al.
Experimental and Therapeutic Medicine (2024) Vol. 28, Iss. 3
Open Access
Acute autoimmune hepatitis following COVID-19 mRNA vaccination: A population-based study using electronic health records in Singapore
Amelia Ng, Desmond Chun Hwee Teo, Sreemanee Raaj Dorajoo, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126462-126462
Closed Access
Autoimmune‐Like Hepatitis Related to SARS‐CoV‐2 Vaccination: Towards a Clearer Definition
Cumali Efe, Sarp Uzun, Matthias S. Matter, et al.
Liver International (2024) Vol. 45, Iss. 1
Closed Access
SARS-CoV-2 Vaccination Response in Japanese Patients with Autoimmune Hepatitis: Results of Propensity Score-Matched Case–Control Study
Kei Moriya, Tomoko Nakakita, Natsuki Nakayama, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 16, pp. 5411-5411
Open Access | Times Cited: 1
Page 1

Scroll to top